Balancing Safety And Sustainability In Pharma Packaging

The evolution of pharma packaging has always mirrored the healthcare sector’s needs. Pharmaceutical companies prioritize packaging that: Meets storage specifications to keep drugs uncontaminated Complies with stringent regulations Facilitates efficient market distribution During the peak of COVID-19, these traits were crucial. Now, as the global economy and supply chains regain stability, the industry must shift […]

ChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market

ChargePoint Technology, a leading specialist in powder containment and aseptic transfer solutions, is expanding its presence in India, and announced today the launch of its new subsidiary, ChargePoint UK Private Ltd. The subsidiary will focus on business development and providing support services tailored to the Indian market. To support its expansion in the region, ChargePoint […]

EFPIA Commits To Decarbonize The Pharmaceutical Industry

The EFPIA or European Federation of Pharmaceutical Industries and Associations and its members have announced a commitment to science-based targets aimed at decarbonizing the pharmaceutical sector, emphasizing environmental sustainability. The organization stressed the importance of moving away from traditional practices and adopting innovative methods that minimize environmental impact. Strategies for Enhancing Environmental Sustainability EFPIA’s outlined […]

Pharmaceutical Packaging Market To Reach $464.4 Billion

Experts forecast substantial growth in the global pharmaceutical packaging sector. Market value is predicted to rise from US$ 133.6 billion in 2022 to an impressive US$ 464.4 billion by 2031. This surge corresponds to a notable CAGR of 14.8% from 2023 to 2031, driven by the growing need for advanced packaging solutions in pharmaceuticals. Factors […]

Leveraging Contract Packaging For Greener Pharma Solutions

GlobalData’s analysis happens to reveal quite a significant uptick in the mention of emissions within pharmaceutical company filings. In 2023, this keyword appeared 6,272 times—a 33% increase from the previous year and a staggering 542% rise from 2016. This highlights the growing emphasis on sustainability across various industries as the pressure to meet net-zero emissions […]

Enhancing Transparency In Medicinal Products Through PMS

The European Medicines Agency has set forth its objectives for the Product Management Service (PMS), aiming for it to serve as a definitive repository of medicinal product information. PMS functions as a comprehensive database accessible to regulators and marketing authorization holders, with a subset of its data available to the public via a dedicated portal, […]

Key Factors In Clinical Trial Management And Cost Control

Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success. At the 13th Annual Clinical Trials in Oncology East Coast 2024 conference in Burlington, Massachusetts, panelists discussed the factors influencing effective outsourcing strategies. Claudia Hesselmann, founder and CEO of ARENSIA Exploratory Medicine, emphasized that while […]

Clinical Trial Supplies Market To Reach $3.72 Bn In 2028

The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 8.9%. This growth in the historical period is attributed to increasing prevalence of chronic diseases, stringent regulatory requirements, rising demand for clinical trials aimed at […]

The FDA Enhances Clarity To Fight Medical Misinformation

On July 8, 2024, the United States FDA revised its draft guidance on tackling misinformation about medical devices and prescription drugs, providing a Q&A format for the industry. These updated suggestions offer various approaches for companies with FDA-approved or FDA-cleared products to counteract misinformation concerning their products. Medical misinformation poses a significant threat to the […]

The $183B Impact of Patent Expirations On Biopharma Giants

The biopharma industry is well-positioned to respond to upcoming patent expirations by pursuing mergers and acquisitions, according to a research note from Morgan Stanley. The report, dated July 11, states that products losing exclusivity through 2030 generate a combined $183.5 billion in annual sales, with Amgen, Bristol Myers Squibb, and Merck facing significant exposure of […]